Development of a Triton X‐100 replacement for effective virus inactivation in biotechnology processes
After the transmission of human viruses through plasma derivatives had been recognized in the early 1980s, virus inactivation and then removal steps have been implemented into their manufacturing processes. These measures have kept plasma derivatives safe ever since and have also served as a barrier...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
2019-12-01
|
| Saila: | Engineering Reports |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1002/eng2.12078 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|